ChromoGenics’ rights issue of approximately MSEK 40 is guaranteed to approximately 80%, corresponding to approximately 33 MSEK
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, NEW ZEALAND, SOUTH AFRICA, CANADA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE.Through guarantee and subscription commitments, ChromoGenics AB (publ) has secured approximately 80% of the rights issue of approximately MSEK 40 with a planned subscription period of 8-22 January 2018. In order to support ChromoGenics’ strategic initiatives, the